Skip to main content
These products are not intended to diagnose, treat, cure, or prevent any disease. Research compounds are sold for laboratory and educational purposes only.
These products are not intended to diagnose, treat, cure, or prevent any disease. Research compounds are sold for laboratory and educational purposes only.
Vial - ARA-290 10mg

Vial – ARA-290 10mg

$179.00
  • Name:
    ARA-290 (Cibinetide; EPO-Derived Peptide)
  • Sequence:
    Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
  • Molecular Formula:
    C₅₁H₈₄N₁₆O₂₁
  • Molecular Weight:
    ≈ 1257.38 g/mol
  • CAS Registry Number:
    1208243-50-8

ARA-290 – COMPREHENSIVE RESEARCH PEPTIDE FOR TISSUE-PROTECTIVE AND INNATE REPAIR RECEPTOR STUDIES

Scientific Overview of ARA-290

ARA-290 is a synthetic peptide derived from erythropoietin (EPO), engineered to selectively activate the innate repair receptor (IRR) without stimulating erythropoiesis.

In in-vitro and in-vivo experimental models, ARA-290 has been studied for its role in:

• Innate Repair Receptor Activation – investigation of peptide interaction with EPOR/CD131 receptor complexes and downstream signaling (Brines et al., 2008)
• Inflammatory Pathway Modulation – evaluation of cytokine signaling and immune response regulation in tissue injury models (Brines & Cerami, 2012)
• Neuroprotective and Tissue Repair Mechanisms – study of peptide-mediated cellular protection and regeneration pathways (Leist et al., 2004)

ARA-290 serves as a key research peptide for exploring tissue protection, inflammatory signaling, and peptide-based repair mechanisms.

COAs

COA_Vial_ARA10VAS0426_ULP

*This peptide is intended solely for laboratory research use. It is not approved for human consumption or therapeutic application.

Skip to content